MedPath

Evaluation of Frequency Lowering Technique

Not Applicable
Completed
Conditions
Hearing Loss
Registration Number
NCT02303210
Lead Sponsor
Phonak AG, Switzerland
Brief Summary

The purpose of this study is to examine two frequency lowering techniques in case of audibility, recognition, distinction, discriminability and sound quality.

Detailed Description

This is a controlled, single blinded and randomised comparative study which is conducted monocentric at Hoerzentrum Oldenburg, Germany. The focus is to test two frequency lowering techniques with an amount of 30 moderate to severe, symmetrically sensorineural hearing impaired adult subjects. The subjects, all of them native German speakers, individually conduct a number of laboratory standard tests and home trials (questionnaires) during 6 months including seven appointments of 2 hours.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • female and male adults (>18 years old)
  • mild to severe Hearing Loss
  • symmetric Hearing Loss
  • german native speakers
Exclusion Criteria
  • persons who are not able to attend multiple appointments
  • persons who are not able to handle a hearing aid
  • persons with a mental handicap
  • persons with limited access to multiple hearing situations
  • persons with psychological disease
  • no acclimatization to hearing aids

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Audibility improvement (Delta of dB SPL thresholds) of high frequency sounds measured with a Phoneme Perception Test.6 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hoerzentrum Oldenburg

🇩🇪

Oldenburg, Niedersachsen, Germany

Hoerzentrum Oldenburg
🇩🇪Oldenburg, Niedersachsen, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.